What is the current market size?

The global STD Rapid Test Kits market size was valued at USD 1.2 billion in 2023, reflecting steady adoption in diagnostics and point-of-care settings.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, driven by rising prevalence of sexually transmitted diseases and healthcare accessibility.

What are the key growth drivers?

Key drivers include increasing awareness of sexual health, demand for rapid results, and government initiatives promoting early disease detection.

What challenges does the market face?

High costs of advanced kits, limited reimbursement policies, and regulatory complexities hinder market growth, particularly in low-income regions.

Which regions lead the market?

North America dominates the market due to robust healthcare infrastructure, followed by Europe, while Asia-Pacific shows the highest growth potential.

Who are the leading companies?

Top players include Abbott Laboratories, Becton Dickinson, and Siemens Healthineers, focusing on innovation and expanding distribution networks.

What are future opportunities?

Opportunities lie in multiplex testing for multiple pathogens, telemedicine integration, and partnerships with NGOs for rural healthcare access.

How does technology impact the market?

Advances in biosensors, AI-driven diagnostics, and portable devices enhance accuracy and accessibility, accelerating market adoption.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA ensure compliance, while varying standards across regions necessitate tailored strategies for market entry.

STD Rapid Test Kits Growth Analysis & Future Outlook 2033

STD Rapid Test Kits by Application (Diagnostic Centers, Hospitals, Home Use), by Types (HBV Test Kits, HCV Test Kits, HIV Test Kits, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 13.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 13.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

STD Rapid Test Kits Market Size | CAGR 13.4 Forecast 2033

STD Rapid Test Kits Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 13.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 13.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

STD Rapid Test Kits Market Overview

The STD Rapid Test Kits market refers to diagnostic solutions enabling swift, at-home, or point-of-care detection of sexually transmitted diseases (STDs) such as HIV, chlamydia, gonorrhea, and syphilis. Amid rising global health awareness and the urgency for early intervention, this market has become a critical pillar of public health infrastructure. The STD Rapid Test Kits market size was estimated at $1.2 billion in 2026, reflecting a 10.5% CAGR from 2026–2033, driven by macro-level shifts in consumer behavior, regulatory tailwinds, and technological innovation.

Loading chart…

Key forces shaping the industry expansion include advancements in multiplex testing technologies, which allow simultaneous detection of multiple pathogens, and stringent regulatory frameworks in the EU and North America fostering product standardization. Consumer demand for privacy and convenience is accelerating the adoption of at-home testing, while supply-chain innovations are reducing costs. North America dominates the market (45% share in 2026), but Asia-Pacific is the fastest-growing region, fueled by rising healthcare access in India and China. Strategic partnerships between diagnostics firms and telemedicine platforms will further accelerate market forecast growth, positioning the sector as a cornerstone of decentralized healthcare by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.29 billion
Growth rate	CAGR of 13.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Siemens; Abbott Laboratories; Bio-Rad Laboratories; BioMerieux; Qiagen; Meridian Bioscience; Hologic; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

STD Rapid Test Kits market expansion is fueled by rising global STD prevalence, particularly among young, sexually active populations, and increased awareness of asymptomatic infections. Technological innovations, such as multiplex testing for multiple pathogens in a single test, enhance diagnostic efficiency, driving adoption in clinical and home settings.

Government and non-profit initiatives promoting STD screening programs are accelerating market growth. For instance, the CDC's expanded funding for community-based testing in the U.S. and WHO’s global health campaigns underscore public health priorities, directly influencing STD Rapid Test Kits market size expansion.

Restraints2 items

Stringent regulatory requirements for diagnostic devices, particularly in regions like Europe and North America, delay product approvals and increase compliance costs. This slows market entry for smaller players and limits innovation in niche segments.

High costs of advanced rapid test kits, coupled with limited reimbursement policies in emerging markets, hinder widespread adoption. Price-sensitive consumers often opt for cheaper, less accurate alternatives, suppressing growth in lower-income regions.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential, driven by improving healthcare infrastructure and rising disposable incomes. Strategic partnerships with local distributors can enhance market penetration and align with regional growth forecast targets.

Integration of digital health platforms for test result tracking and telemedicine consultations offers a competitive edge. This convergence addresses unmet needs for privacy and convenience, particularly in home-testing segments.

Challenges2 items

Supply chain vulnerabilities, including raw material shortages and geopolitical tensions, disrupt production. The reliance on specialized reagents and single-source suppliers heightens fragility in the STD Rapid Test Kits market.

Intensifying competition from generic manufacturers erodes profit margins. Price wars and patent expirations in mature markets risk devaluing product differentiation, forcing companies to prioritize R&D for next-generation diagnostics.

Market Segmentation

Loading chart…

Application Segmentation in the STD Rapid Test Kits market is critical for understanding adoption patterns. The market is divided into clinical diagnosis, home use, and public health screening. Clinical diagnosis dominates due to the need for rapid, accurate results in healthcare settings, particularly for sexually transmitted infections like HIV, syphilis, and chlamydia. Home-use kits are growing due to increasing consumer preference for privacy and convenience, especially in regions with limited healthcare access. Public health screening programs, driven by government initiatives and NGOs, target high-risk populations, contributing to market expansion. This STD Rapid Test Kits segmentation highlights how application-specific demands shape market dynamics, with clinical and public health segments accounting for 65% and 25% of the total share, respectively.

Types Segmentation categorizes the market into antigen-based tests and antibody-based tests. Antigen-based tests detect pathogen proteins, offering faster results for acute infections, while antibody-based tests identify immune responses, suitable for long-term monitoring. Antigen-based kits dominate in acute care settings, particularly for HIV and gonorrhea, due to their high specificity. Antibody-based kits are preferred in screening campaigns for diseases like syphilis, where early immune response detection is critical. Technological advancements in lateral flow assays and multiplex testing are driving innovation in both segments. The market taxonomy reveals that antigen-based tests hold 55% of the market share, with antibody-based tests expanding at a higher CAGR due to increasing demand for early-stage diagnostics.

STD Rapid Test Kits Segmentation Breakdown9 items

Application

Diagnostic Centers

Hospitals

Home Use

Types

HBV Test Kits

HCV Test Kits

HIV Test Kits

Others

Regional Insights

Loading chart…

The STD Rapid Test Kits market is dominated by North America, contributing approximately 35% of global demand, driven by advanced healthcare infrastructure, high awareness, and robust investment in diagnostic technologies. Asia Pacific emerges as the fastest-growing region, fueled by rising STI prevalence, government initiatives, and improving healthcare accessibility. Regional forecast models highlight Asia Pacific's exponential potential, supported by a young, urbanizing population and increasing private-sector participation.

Key Drivers by Region13 items

North America (35%):

High adoption of rapid diagnostics due to widespread sexual health education and reimbursement policies.

Strong regulatory frameworks and partnerships with public health agencies for STI screening programs.

Europe (30%):

EU-funded initiatives promoting equitable access to diagnostic tools across member states.

Mature healthcare ecosystems with emphasis on early detection and treatment of STIs.

Asia Pacific (25%):

Demographic growth and urbanization creating demand for cost-effective, portable testing solutions.

Government investments in rural healthcare infrastructure and private-public partnerships.

Latin America (7%):

Expanding healthcare coverage in Brazil and Mexico, coupled with NGO-led awareness campaigns.

Middle East & Africa (3%):

Growing focus on HIV/STI prevention in sub-Saharan Africa and Gulf Cooperation Council (GCC) nations.

Competitive Landscape

The STD Rapid Test Kits competitive landscape is moderately consolidated, with global players dominating high-income markets and regional firms capturing niche segments in emerging economies. Key competitive dynamics are shaped by pricing strategies (premium vs. cost-competitive models), regulatory approvals (FDA, CE), and product innovation (multiplex testing, rapid antigen detection). Distribution networks, particularly in hospital and point-of-care channels, also serve as critical differentiation factors. While global firms leverage economies of scale and established R&D pipelines, local players focus on affordability and localized partnerships to address market-specific needs.

Competitive strategies emphasize M&A activity, OEM collaborations, and geographic expansion to strengthen market presence. Differentiation arises from technology (e.g., isothermal amplification vs. lateral flow assays) and service models (centralized vs. decentralized testing frameworks). A major challenge is rising compliance costs due to evolving regulatory standards, particularly in low-resource settings. Channel strength and customization capabilities further influence vendor selection, with companies balancing margin pressures against investments in quality assurance and supply chain resilience.

Roche: Regional expansion in Asia-Pacific through distributor partnerships

Siemens: OEM tie-ups for hospital diagnostics integration

Abbott Laboratories: Premium pricing with innovation in multiplex assays

Bio-Rad Laboratories: Cost advantages via local manufacturing in emerging markets

BioMerieux: Service model enhancements with digital connectivity

Qiagen: Vertical integration to reduce supply chain risks

Key STD Rapid Test Kits Companies9 items

Roche

Siemens

Abbott Laboratories

Bio-Rad Laboratories

BioMerieux

Qiagen

Meridian Bioscience

Hologic

Creative Diagnostics

Market Ecosystem

The STD Rapid Test Kits ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is created through the development of accurate, user-friendly diagnostic solutions and captured via sales to healthcare providers, laboratories, and consumers. Regulatory compliance and technological innovation act as critical enablers across the value chain analysis.

Raw material/component suppliers — provide antigens, antibodies, and manufacturing consumables

OEMs/Manufacturers — design and produce rapid test kits using lateral flow or immunoassay technologies

Technology providers — develop proprietary testing platforms and digital connectivity features

Distributors/channel partners — manage logistics and commercialization through healthcare networks

End users/buyers — include hospitals, clinics, pharmacies, and direct-to-consumer platforms

Regulators/standards bodies — enforce quality benchmarks and approval processes for test kit commercialization

Service providers — support post-purchase training, data management, and test result interpretation services

Control points reside with regulators governing product approvals and healthcare providers determining procurement pathways. Dependency risks emerge from raw material availability and proprietary technology licensing. Switching costs for end users are influenced by partnerships between manufacturers and distributors, while interoperability with digital health systems increasingly shapes ecosystem differentiation.

Recent Industry Insights

The STD Rapid Test Kits industry trends have seen significant momentum over the past 18 months, driven by rising demand for point-of-care diagnostics and advancements in multiplex testing technologies. Strategic partnerships have emerged, such as Quest Diagnostics’ collaboration with Hologic to expand access to rapid sexually transmitted infection (STI) testing solutions. In the mergers & acquisitions space, Becton Dickinson (BD) acquired Mologic Ltd.’s rapid diagnostic assets, strengthening its portfolio with novel antigen-detection formats. Product/technology launches highlight innovations like Roche’s AI-integrated rapid test readers, which improve result accuracy, and Alere’s handheld devices for decentralized testing. Regulatory changes have accelerated, with the FDA issuing updated guidelines to streamline approvals for rapid tests targeting chlamydia and gonorrhea. Consumer trends reflect growing preference for at-home testing kits, spurred by telehealth adoption, while enterprise trends prioritize lab-attached systems for high-throughput screening. Funding has surged, with startups like Nurx securing $15M in Series B rounds to scale home testing services, signaling a shift toward decentralized diagnostics as a key growth lever for the sector.

Analyst Overview

The STD Rapid Test Kits market remains a strategically attractive segment, driven by rising prevalence of sexually transmitted infections (STIs) and demand for point-of-care diagnostics. Market attractiveness is underscored by technological advancements enabling faster, more accurate results, while competitive intensity remains moderate, with established players focusing on product differentiation and emerging firms targeting niche applications. The long-term outlook for the STD Rapid Test Kits market is optimistic, supported by growing awareness, government initiatives for STI screening, and expansion into underserved regions.

Key Insights3 items

Innovation landscape highlights multiplex testing capabilities and integration with digital health platforms

Demand-supply balance favors growth, with rising unmet needs in low-resource settings creating opportunities

Risks include regulatory shifts, reimbursement challenges, and potential obsolescence from next-gen molecular diagnostics

Strategic investments in R&D and strategic partnerships will be critical to navigate this dynamic landscape. The STD Rapid Test Kits market outlook suggests sustained growth through 2030, contingent on addressing scalability challenges and maintaining cost-effectiveness.

11 items

1. Executive Summary

2. STD Rapid Test Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global STD Rapid Test Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global STD Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diagnostic Centers

6.1.2. Hospitals

6.1.3. Home Use

6.2. Global STD Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. HBV Test Kits

6.2.2. HCV Test Kits

6.2.3. HIV Test Kits

6.2.4. Others

6.3. Global STD Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global STD Rapid Test Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global STD Rapid Test Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global STD Rapid Test Kits Market Competition by Key Manufacturers

8.1. Global STD Rapid Test Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global STD Rapid Test Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Siemens

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BioMerieux

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Qiagen

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Meridian Bioscience

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Hologic

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Creative Diagnostics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global STD Rapid Test Kits Market

Figure 4: Global STD Rapid Test Kits Market: Drivers

Figure 5: Global STD Rapid Test Kits Market: Challenges

Figure 6: Global STD Rapid Test Kits Market: Trends

Figure 7: Global STD Rapid Test Kits Market: Opportunity

Figure 8: Global STD Rapid Test Kits Market: Restraint

Figure 9: Global STD Rapid Test Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global STD Rapid Test Kits Market Value (USD Million) By Region

Figure 15: Global STD Rapid Test Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global STD Rapid Test Kits Market Value (USD Million) By Region

Figure 23: Global STD Rapid Test Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global STD Rapid Test Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global STD Rapid Test Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global STD Rapid Test Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global STD Rapid Test Kits Market Value (USD Million) By Region

Table 10: Global STD Rapid Test Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global STD Rapid Test Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global STD Rapid Test Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global STD Rapid Test Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Siemens Basic Information And Sales Area

Table 33: Siemens. Products Portfolio

Table 34: Abbott Laboratories Basic Information And Sales Area

Table 35: Abbott Laboratories. Products Portfolio

Table 36: Bio-Rad Laboratories Basic Information And Sales Area

Table 37: Bio-Rad Laboratories. Products Portfolio

Table 38: BioMerieux Basic Information And Sales Area

Table 39: BioMerieux. Products Portfolio

Table 40: Qiagen Basic Information And Sales Area

Table 41: Qiagen. Products Portfolio

Table 42: Meridian Bioscience Basic Information And Sales Area

Table 43: Meridian Bioscience. Products Portfolio

Table 44: Hologic Basic Information And Sales Area

Table 45: Hologic. Products Portfolio

Table 46: Creative Diagnostics Basic Information And Sales Area

Table 47: Creative Diagnostics. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global STD Rapid Test Kits Market Value (USD Million) By Region

Table 53: Global STD Rapid Test Kits Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

STD Rapid Test Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.29 billion
Growth rate	CAGR of 13.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Siemens; Abbott Laboratories; Bio-Rad Laboratories; BioMerieux; Qiagen; Meridian Bioscience; Hologic; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options